Universität zu Köln

Kriz, J., Baues, C., Engenhart-Cabillic, R., Haverkamp, U., Herfart, K., Lukas, P., Pluetschow, A., Schmidberger, H., Staar, S., Fuchs, M., Engert, A. and Eich, H. T. (2017). Quality control of involved field radiotherapy in the HD 13 and HD 14 trials. Strahlenther. Onkol., 193 (2). S. 109 - 116. MUNICH: URBAN & VOGEL. ISSN 1439-099X

Full text not available from this repository.

Abstract

Introduction As part of the foundation of the German Hodgkin Study Group (GHSG) in 1978, a central radiotherapy (RT) reference centre was established to evaluate and to improve the quality of treatment. During the study generations, the quality assurance programs (QAP) were continued and adapted to the demands of each study. The purpose of this article is to demonstrate the results of the fifth study generation and to compare them to the previous findings. Methods With the start of the fourth GHSG study generation (HD10-12), a central prospective review of all diagnostic images was established to create an individual treatment plan for each early stage study patient. The quality of involved field RT was retrospectively evaluated by an expert panel of radiation oncologists. In the fifth study generation (HD13-15), the retrospective review of radiotherapy performed was refined and the results were compared with the findings of the fourth generation. Results The expert panel analyzed the RT planning and application of 1037 (28 %) patients (HD13 n = 465, HD14 n = 572). Simulation films were available in 85 % of cases and verification films in 87 %. RT was assessed as major violation in 46 % (HD13 = 38 %, HD14 = 52 %), minor violation in 9 % (HD13 = 9 %, HD14 = 9 %) and according to the protocol in 45 % (HD13 = 52 %, HD14 = 38 %). Conclusion The value for QAP of RT within the GHSG trials is well known. Still there were several protocol violations. In the future, the QAP program has to be adapted to the requirements of modern RT in malignant lymphoma.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Kriz, J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Baues, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Engenhart-Cabillic, R. UNSPECIFIED UNSPECIFIED UNSPECIFIED Haverkamp, U. UNSPECIFIED UNSPECIFIED UNSPECIFIED Herfart, K. UNSPECIFIED UNSPECIFIED UNSPECIFIED Lukas, P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Pluetschow, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Schmidberger, H. UNSPECIFIED UNSPECIFIED UNSPECIFIED Staar, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Fuchs, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Engert, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Eich, H. T. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-241056
DOI:	10.1007/s00066-016-1036-2
Journal or Publication Title:	Strahlenther. Onkol.
Volume:	193
Number:	2
Page Range:	S. 109 - 116
Date:	2017
Publisher:	URBAN & VOGEL
Place of Publication:	MUNICH
ISSN:	1439-099X
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language HODGKIN-STUDY-GROUP; LYMPHOMA FINAL ANALYSIS; STUDY-GROUP GHSG; DISEASE; CHEMOTHERAPY; PATTERNS; CARE; INTENSITY; PROGRAM Multiple languages Oncology; Radiology, Nuclear Medicine & Medical Imaging Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/24105